Company Description
Caliber Imaging & Diagnostics (OTC Link: LCDX) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $3.7M.
LCDX stock has gained 500.0% over the past year. Shares last traded at $0.0006.
This page provides a comprehensive overview of LCDX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Caliber Imaging & Diagnostics (LCDX) stock last traded at $0.0006. Over the past 12 months, the stock has gained 500.0%. At a market capitalization of $3.7M, LCDX is classified as a micro-cap stock with approximately 8.5M shares outstanding.
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Caliber Imaging & Diagnostics (LCDX) currently stands at 3.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Caliber Imaging & Diagnostics (LCDX) currently stands at 2.4 days, down 86.7% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 79.7% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 102.9 days.
LCDX Company Profile & Sector Positioning
Caliber Imaging & Diagnostics (LCDX) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing LCDX often look at related companies in the same sector, including Odyssey Health Inc (ODYY), Qscreen AI Inc (PMEDF), Kelyniam Global Inc (KLYG), Lattice Biologic (LBLTF), and Bioelectronics Corp (BIEL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LCDX's relative position within its industry.